Search company, investor...

Investors Count

2

Deal Terms

1

Funding, Valuation & Revenue

2 Fundings

TI Health's latest funding round was a Acquired for on March 1, 2023.

TI Health's valuation in August 2018 was $33.5 - $42.5M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

3/1/2023

Acquired

$99M

0

FY undefined

5

8/7/2018

Acquired Unit - Fin

$33.5 - $42.5M

0

FY undefined

10

Date

3/1/2023

8/7/2018

Round

Acquired

Acquired Unit - Fin

Amount

Investors

Valuation

$99M

$33.5 - $42.5M

Revenue

0

FY undefined

0

FY undefined

Sources

5

10

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

TI Health Deal Terms

1 Deal Term

TI Health's deal structure is available for 1 funding round, including their Acquired Unit - Fin from August 07, 2018.

Round

Acquired Unit - Fin

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

$99M

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired Unit - Fin

$99M

$99M

$99M

$99M

TI Health Investors

2 Investors

TI Health has 2 investors. Real Chemistry invested in TI Health's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

3/1/2023

3/1/2023

1
Acquired

Corporation

California

00/00/0000

00/00/0000

Haylard Capital

Subscribe to see more

Private Equity

New York

First funding

3/1/2023

00/00/0000

Last Funding

3/1/2023

00/00/0000

Investor

Haylard Capital

Rounds

1
Acquired

Subscribe to see more

Board Seats

Type

Corporation

Private Equity

Location

California

New York

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare TI Health to Competitors

Prognos Health Logo
Prognos Health

Prognos Health provides a healthcare analytics platform. The platform stores and processes clinical lab test data to help pharma, payers, and diagnostics companies predict disease to drive earlier intervention. The company was founded in 2010 and is based in New York, New York.

Verato Logo
Verato

Verato provides software-as-a-service solutions. The company offers data management, identity analytics, integrations, and more. It serves healthcare providers, government, health information exchange, and other sectors. It was formerly known as Araxid. The company was founded in 2012 and is based in McLean, Virginia.

HealthVerity Logo
HealthVerity

HealthVerity provides technologies and software tools for the discovery and integration of optimal patient data sets. It offers a healthcare data and patient informatics platform designed to offer enhanced data discovery and distribution. It works with pharmaceuticals and hospitals to increase the insights from data supplier relationships. The company was founded in 2014 and is based in Philadelphia, Pennsylvania.

Syntropy Logo
Syntropy

Syntropy is a company that focuses on the biomedical data sector, providing solutions for data curation and collaboration. The company offers services to healthcare organizations, helping them to integrate and harmonize complex data sets, and facilitating collaboration within and across organizations. Syntropy primarily serves the healthcare, life sciences, and government sectors. It is based in Boston, Massachusetts.

Seqster Logo
Seqster

Seqster is a healthcare technology company that focuses on breaking down health data silos. It operates in the healthcare and life sciences industries. The company's main service is an enterprise operating system that aggregates disparate health data sources into a single, comprehensive view of a patient in real-time. This includes data from electronic health records, genomic DNA, wearables, pharmacy, and social determinants of health. Seqster primarily sells to the life sciences industry and the healthcare sector. It was founded in 2016 and is based in San Diego, California.

K
Kythera Labs

Kythera Labs is a data management and analytics company operating in the healthcare sector. The company provides a platform that processes healthcare data and applies machine learning to identify and predict behavioral patterns of various healthcare entities. It primarily serves the healthcare industry, including hospitals, pharmaceutical manufacturers, technology companies, and government entities. It was founded in 2019 and is based in Franklin, Tennessee.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.